Robust federal investment in and by the agency has led to innovative bench-to-bedside discoveries that have resulted in paradigm-shifting advances in blood disease treatment and curesfrom interventions that prevent stroke in young children with sickle cell disease to methods of engineering our own immune cells to attack tumors and beat cancer.